BeOne Medicines AG (HKG:6160)
Hong Kong · Delayed Price · Currency is HKD 201.40
-0.60 (-0.30%)
Jan 27, 2026, 11:59 AM HKT
BeOne Medicines AG Market Cap
BeOne Medicines AG has a market cap or net worth of 292.81 billion as of January 26, 2026. Its market cap has increased by 101.85% in one year.
Market Cap
292.81B
Enterprise Value
269.28B
Revenue
38.69B
Ranking
n/a
PE Ratio
548.98
Stock Price
201.40
Market Cap Chart
Since February 3, 2016, BeOne Medicines AG's market cap has increased from 6.70B to 292.81B, an increase of 4,272.35%. That is a compound annual growth rate of 46.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 292.81B | 11.90% |
| Dec 31, 2025 | 261.67B | 71.29% |
| Dec 31, 2024 | 152.77B | 4.09% |
| Dec 29, 2023 | 146.76B | -17.60% |
| Dec 30, 2022 | 178.11B | -17.96% |
| Dec 31, 2021 | 217.12B | 19.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Feb 3, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| WuXi Biologics | 162.53B |
| Innovent Biologics | 145.19B |
| Sino Biopharmaceutical | 118.52B |
| Akeso | 107.31B |
| Sichuan Kelun-Biotech Biopharmaceutical | 100.18B |
| 3SBio | 60.84B |
| RemeGen | 58.79B |
| Shanghai Junshi Biosciences | 37.04B |